PureHealth has signed a Memorandum of Understanding (MoU) with the National Multiple Sclerosis Society (NMSS) to strengthen awareness, support earlier diagnosis and improve care for multiple sclerosis (MS) patients across the UAE.
The MoU brings together PureHealth’s clinical expertise and integrated healthcare capabilities with the National Multiple Sclerosis Society’s (NMSS) leadership in advocacy, education and community support.
The PureHealth-NMSS partnership also aims to accelerate research initiatives and contribute to global efforts to advance the understanding, treatment and eventual cure of MS.
MS, a chronic neurological condition affecting the brain and spinal cord, can lead to a wide range of physical, cognitive and mobility challenges, often impacting individuals during early to mid-adulthood. It affects an estimated 2.9 million people globally.
PureHealth-NMSS MoU supports earlier diagnosis and improved MS care pathways
A key focus of the collaboration is to support the implementation of the UAE’s first Multiple Sclerosis (MS) Treatment Guidelines, developed and published by the National Multiple Sclerosis Society (NMSS), across clinical practice and healthcare payer systems to help standardize and improve patient care.
This is expected to improve how patients are diagnosed, treated and supported, including earlier access to highly effective treatments based on the latest evidence, improved insurance coverage alignment, and more consistent care delivery across the UAE.
The partnership will also strengthen support for vulnerable patient groups, including pregnant and breastfeeding women and children living with multiple sclerosis, while promoting a more patient-centered model of care that encourages individuals to play an active role in treatment planning and decision-making.
According to the statement, it will also contribute to strengthening MS research and data in the UAE, supporting the development of local disease insights and informing national studies, registries and future publications through closer collaboration between clinicians, researchers and health authorities.
Another key pillar of the partnership is strengthening clinical capabilities of more than 1,300 healthcare professionals through a series of Continuing Medical Education (CME)-accredited sessions led by MS specialists, and aligned with the Department of Health – Abu Dhabi’s (DoH) direction.
The initiative places a strong emphasis on empowering nurses in care coordination and patient education, while extending engagement to patients and caregivers through dedicated community sessions. Targeted awareness initiatives, including webinars, workshops and digital campaigns, will further improve public understanding of MS and support earlier symptom awareness.
Leya Aldamani, Chief Sustainability Officer at PureHealth, said that, “This partnership reflects our commitment to bringing together clinical expertise, data and coordinated care pathways to enable earlier intervention and improve long-term outcomes. By strengthening clinical capability and embedding more patient-centered models of care, our goal is to contribute to building a more connected and proactive healthcare system.”
Maral Alexandrian, Acting Executive Director of the NMSS, remarked that, “Our partnership with PureHealth reflects a shared commitment to strengthening the MS ecosystem in the UAE through greater awareness, earlier intervention and more coordinated support for individuals and families impacted by the condition.”
